Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients

International Psychogeriatrics

Volumn 24, Issue 4, 2012, Pages 606-613

  Marengoni, A ^a   Bianchi, G ^a   Nobili, A ^b   Tettamanti, M ^b   Pasina, L ^b   Corrao, S ^c   Salerno, F ^d   Iorio, A ^e   Marcucci, M ^e   Mannucci, P M ^f  

^a UNIVERSITY OF BRESCIA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

antidepressants; dementia; elderly; hospitalization; prescription

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

AGED; ARTICLE; DEMENTIA; DRUG USE; FEMALE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE;

AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; DEMENTIA; DEPRESSION; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; SEX FACTORS;

EID: 84859061085     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610211002353     Document Type: Article

References (23)

1. Alexopoulos, G. S., Buckwalter, K., Olin, J., Martinez, R., Wainscott, C. and Krishnan, K. R. (2002). Comorbidity of late life depression: an opportunity for research on mechanism and treatment. Biological Psychiatry, 52, 543-558.
2. Arve, S., Tilvis, R. S., Lehtonen, A., ValVanne, J. and Sairanen, S. (1999). Coexistence of lowered mood and cognitive impairment of elderly people in five birth cohorts. Aging (Milano), 11, 90-95.
3. Caughey, G. E., Roughead, E. E., Shakib, S., McDermott, R. A., Vitry, A. I. and Gilbert, A. L. (2010). Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age and Ageing, 39, 488-494.
4. Charlson, M. E., Pompei, P., Ales, K. L. and MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases, 40, 373-383.
5. Covinsky, K. E., Kahana, E., Chin, M. H., Palmer, R. M., Fortinsky, R. H. and Landefeld, C. S. (1999). Depressive symptoms and 3-year mortality in older hospitalized medical patients. Annals of Internal Medicine, 130, 563-569.
6. Dolder, C., Nelson, M. and Stump, A. (2010). Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients. Drugs and Aging, 27, 625-640.
7. Henry, G, Williamson, D. and Tampi, R. R. (2011). Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence. American Journal of Alzheimer's Disease and Other Dementias, 26, 169-183.
8. Koenig, H. G. and George, L. K. (1998). Depression and physical disability outcomes in depressed medically ill hospitalized older adults. American Journal of Geriatric Psychiatry, 6, 230-247.
9. Meyers, B. S. (1998) Depression and dementia: comorbidities, identification, and treatment. Journal of Geriatric Psychiatry and Neurology, 11, 201-205.
10. Meyers, B. S. and Jeste,D. V. (2010). Geriatric Psychopharmacology: evolution of a discipline. Journal of Clinical Psychiatry, 71, 1416-1424.
11. Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V. and Ustun, B. (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet, 370, 851-858.
12. Parabiaghi, A. et al. (2011). Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness. European Journal of Clinical Pharmacology, 67, 1077-1083.
13. Pincus, H. A. et al. (1998). Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA, 279, 526-531.
14. Prince, M. et al. (2007). No health without mental health. Lancet, 370, 859-877.
15. Ray, W. A., Tharpa, P. B. and Gideon, P. (2000) Benzodiazepines and the risk of falls in nursing home residents. Journal of the American Geriatrics Society, 48, 682-685.
16. Rosenberg, P. B. et al. for the DIADS-2 Research Group (2010). Sertraline for the treatment of depression in Alzheimer disease. American Journal of Geriatric Psychiatry, 18, 136-145.
17. Schweitzer, I. and Tuckwell, V. (1998). Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression. Drug Safety, 19, 455-464.
18. Seitz, D. P., Gill, S. S. and Conn, D. K. (2010). Citalopram versus other antidepressants for late-life depression: a systematic review and meta-analysis. International Journal of Geriatric Psychiatry, 25, 1296-1305.
19. Simonson, W. and Feinberg, J. L. (2005). Medication-related problems in the elderly: defining the issue and identifying solutions. Drugs and Aging, 22, 559-569.
20. Stitt, D. M., Elliott, D. P. and Thompson, S. N. (2011). Medication discrepancies identified at time of hospital discharge in a geriatric population. American Journal of Geriatric Pharmacotherapy, 9, 234-240.
21. Wolitzky-Taylor, K. B., Castriotta, N., Lenze, E. J., Stanley, M. A. and Craske, M. G. (2010). Anxiety disorders in older adults: a comprehensive review. Depression and Anxiety, 27, 190-211.
22. World Health Organization (1987). International Classification of Diseases, Injuries, and Causes of Death. Ninth Revision (ICD-9).Geneva: WHO.
23. World Health Organization (1990). Guidelines for ATC Classification. Oslo: WHO. Collaborating Centre for Drug Statistics Methodology, Norway and Nordic Councils on Medicines.